[Clinical aspects and drug therapy of Parkinson's syndrome].
D000661:Amphetamine / Q000627:therapeutic use*; D004155:Diphenhydramine / Q000627:therapeutic use*; D006801:Humans; D010276:Parasympatholytics / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000175:diagnosis* / Q000188:drug therapy*; D010301:Parkinson Disease, Postencephalitic / Q000175:diagnosis* / Q000188:drug therapy*; D011736:Pyridoxine / Q000627:therapeutic use*; D012601:Scopolamine / Q000627:therapeutic use*
D010276:Parasympatholytics; D004155:Diphenhydramine; D000661:Amphetamine; D012601:Scopolamine; D011736:Pyridoxine
Klinik und medikamentöse Therapie des Parkinson-Syndroms.